Energesis Pharmaceuticals
Pioneering a novel pathway in treating obesity and diabetes by enhancing the body's energy expenditure.
2 employees · est. 2009
Glyscend Therapeutics
Advancing a new class of oral gut-targeted polymeric drugs for the treatment of T2D and Obesity
5 employees · est. 2014 · Lowell, United States
Energesis Pharmaceuticals is the older company (2009 vs 2014).
Side-by-Side Comparison
| Metric | Energesis Pharmaceuticals | Glyscend Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2009 older | 2014 |
| Headquarters | ||
| Headquarters | Not tracked yet | Lowell, United States |
| Employees | ||
| Employees | 2 | 5 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Grant | Series A |
| Total Funding | ||
| Total Funding | $150.00K | $22.43M |
| Funding Rounds | ||
| Funding Rounds | 2 | 6 |
| Services | ||
| Services | Not tracked yet | Development of novel oral drugs for metabolic diseases, Research and development of gut-targeted polymer therapies, Conducting clinical trials for innovative drug candidates |
| Target Customers | ||
| Target Customers | Not tracked yet | Type 2 diabetic patients, Overweight individuals, Obese patients, Healthcare providers specializing in metabolic diseases |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Obesity Treatment, Diabetes Treatment, Metabolic Conditions, Drug Discovery, Energy Expenditure, Weight Management, Innovative Drugs, Metabolic Diseases, Pharmaceutical Company | Oral Gut-targeted Drugs, Polymeric Therapeutics, Type 2 Diabetes Treatment, Obesity Treatment, Duodenal Exclusion Therapy, Metabolic Health, Bariatric Surgery Alternative, Non-invasive Treatment, Intestinal Coating Technology, Neurohormonal Pathway Inhibition, Glucose Level Control, Endocrinology Innovation, Primary Care Advancement, Chronic Condition Management |
| Website | ||
| Website | energesispharma.com | glyscend.com |
About Energesis Pharmaceuticals
Energesis Pharmaceuticals is a biotechnology startup that was founded in 2009. The company is focused on pioneering a novel pathway in treating obesity and diabetes by enhancing the body's energy expenditure. Unlike traditional approaches that mainly tackle the intake side of weight management, Ener...
About Glyscend Therapeutics
Glyscend Therapeutics, founded in 2014, is at the forefront of innovations in the biopharma and biotechnology sectors. With a strong focus on health and wellness, this United States-based company is rapidly advancing a revolutionary approach to treating metabolic indications such as type 2 diabetes...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Energesis Pharmaceuticals and Glyscend Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Energesis Pharmaceutic... and Glyscend Therapeutics — by email.
Frequently Asked Questions
Compare Energesis Pharmaceuticals with someone else
Start typing a company name or domain.